Table 1.
Histopathological types of breast cancer (BC) in all patients.
| Histopathological Type | Number n = (%) |
|---|---|
| Infiltrating ductal carcinoma NOS (NST/no special type carcinoma) | 147 (62.55%) |
| Lobular carcinoma NOS | 19 (8.09%) |
| Invasive carcinoma NST with medullary features (CMF) | 12 (5.11%) |
| Carcinoma of mixed type | 12 (5.11%) |
| Mucinous adenocarcinoma | 9 (3.83%) |
| Malignant Phyllodes Tumor | 7 (2.98%) |
| Metaplastic Carcinoma NOS | 6 (2.55%) |
| Ductal Carcinoma in Situ (DCIS) with Microinvasion | 6 (2.55%) |
| Tubular Carcinoma | 2 (0.85%) |
| Neuroendocrine Carcinoma NOS | 2 (0.85%) |
| Cribriform Carcinoma NOS | 2 (0.85%) |
| Intraductal papillary adenocarcinoma with invasion | 2 (0.85%) |
| Invasive Micropapillary Carcinoma | 2 (0.85%) |
| Angiosarcoma | 2 (0.85%) |
| Apocrine adenocarcinoma | 1 (0.43%) |
| Adenoid Cystic Carcinoma | 1 (0.43%) |
| Encapsulated papillary carcinoma with invasion | 1 (0.43%) |
| Primary Hodgkin‘s Lymphoma of the Breast | 1 (0.43%) |
| Primary Breast Diffuse Large B-Cell Lymphoma (DLBCL) | 1 (0.43%) |
NOS = not otherwise specified.